Medical Equipment - Dallas, Texas, US
BioLum Sciences specializes in bioanalytical chemistry for reactive oxygen and nitrogen species (RONS) centered around our core analysis platform and chemiluminescent assays. BioLum's technology measures biomarkers in exhaled breath condensate, blood, and other samples, empowering pharmaceutical developers and clinicians with tools to develop and personalize treatments for cardiovascular disease, asthma, chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension (PAH), and others. We currently offer novel, highly selective chemiluminescent research kits for NO (nitric oxide) and ONOO- (peroxynitrite) for drug discovery and efficacy testing. We also provide R&D services in assay development, compound analysis, and specific analyte measurements, with an emphasis on oxidative stress and nitric oxide signaling. With the advent of biomarker analysis for monitoring disease severity and progression, there is a desire to shift towards remote patient monitoring via non-invasive biomarkers to improve treatment plans and lower overall costs on the healthcare system. Our initial programs are focused on cardiovascular disease, asthma, and copd. Our blood analysis product measures NO (nitric oxide) in the blood using a finger-prick test. This point-of-care test will provide physicians, researchers, and patients a critical gauge of endothelial dysfunction and cardiovascular health. Our breath analysis product, the BioSense AMD (Airway Monitoring Device) for H2O2 (hydrogen peroxide), provides a ‘window into the lung’ by measuring oxidative stress in exhaled breath condensate (EBC). Our test requires no complicated breathing maneuvers, allowing reliable at-home monitoring. Frequent, objective measurements of lung function offer significant patient benefits, allow physicians to optimize treatment, and enable researchers to stratify patients to better understand respiratory disease states.
Outlook
Hubspot
WordPress.org
Google Apps
Google Analytics